Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Nicolai Grebenchtchikov"'
Autor:
Laura Diepeveen, Rian Roelofs, Nicolai Grebenchtchikov, Rachel van Swelm, Leon Kautz, Dorine Swinkels
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254851 (2021)
Erythroferrone (ERFE), the erythroid regulator of iron metabolism, inhibits hepcidin to increase iron availability for erythropoiesis. ERFE plays a pathological role during ineffective erythropoiesis as occurs in X-linked sideroblastic anemia (XLSA)
Externí odkaz:
https://doaj.org/article/173e5fa918e9448cb8c2232858c56c27
Autor:
Tommaso De Marchi, Mieke A. Timmermans, Anieta M. Sieuwerts, Marcel Smid, Maxime P. Look, Nicolai Grebenchtchikov, Fred C. G. J. Sweep, Jan G. Smits, Viktor Magdolen, Carolien H. M. van Deurzen, John A. Foekens, Arzu Umar, John W. Martens
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract In a previous study, we detected a significant association between phosphoserine aminotransferase 1 (PSAT1) hyper-methylation and mRNA levels to outcome to tamoxifen treatment in recurrent disease. We here aimed to study the association of P
Externí odkaz:
https://doaj.org/article/dbc96afce5a543d8b843426a5e4e8e64
Autor:
Rachel P. L. van Swelm, Dorine W. Swinkels, Laura E. Diepeveen, Léon Kautz, Rian Roelofs, Nicolai Grebenchtchikov
Publikováno v:
PLoS One, 16
PLoS One, 16, 7
PLoS ONE
PLoS ONE, Public Library of Science, 2021, 16 (7), 14 p. ⟨10.1371/journal.pone.0254851⟩
PLoS ONE, Vol 16, Iss 7, p e0254851 (2021)
PLoS ONE, 2021, 16 (7), 14 p. ⟨10.1371/journal.pone.0254851⟩
PLoS One, 16, 7
PLoS ONE
PLoS ONE, Public Library of Science, 2021, 16 (7), 14 p. ⟨10.1371/journal.pone.0254851⟩
PLoS ONE, Vol 16, Iss 7, p e0254851 (2021)
PLoS ONE, 2021, 16 (7), 14 p. ⟨10.1371/journal.pone.0254851⟩
Erythroferrone (ERFE), the erythroid regulator of iron metabolism, inhibits hepcidin to increase iron availability for erythropoiesis. ERFE plays a pathological role during ineffective erythropoiesis as occurs in X-linked sideroblastic anemia (XLSA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73c7be2acbf82db7fcefd0bf3eff6fde
http://hdl.handle.net/2066/236818
http://hdl.handle.net/2066/236818
Autor:
Thierry Calandra, Marieke Emonts, Peter W. M. Hermans, Fred C.G.J. Sweep, Nicolai Grebenchtchikov, Veronique Erard, Anne Laure Chanson, Jan A. Hazelzet, Pascal Renner, Marlies Knaup, Anneke Geurts-Moespot
Publikováno v:
Clinical Infectious Diseases, 44, 1321-1328. Oxford University Press
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 44, 1321-8
Clinical Infectious Diseases, 44, 10, pp. 1321-8
Clinical Infectious Diseases, vol. 44, no. 10, pp. 1321-1328
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 44, 1321-8
Clinical Infectious Diseases, 44, 10, pp. 1321-8
Clinical Infectious Diseases, vol. 44, no. 10, pp. 1321-1328
Contains fulltext : 52472.pdf (Publisher’s version ) (Closed access) BACKGROUND: Identification of new therapeutic targets remains an imperative goal to improve the morbidity and mortality associated with severe sepsis and septic shock. Macrophage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5292c2e9ebeb67497f73683e792313f5
http://doc.rero.ch/record/295638/files/44-10-1321.pdf
http://doc.rero.ch/record/295638/files/44-10-1321.pdf
Autor:
Linda Heijmen, Anneke Geurts-Moespot, Paul N. Span, Carla M.L. van Herpen, Annemarie M. J. Thijs, Hanneke W. M. van Laarhoven, Nicolai Grebenchtchikov, Fred C.G.J. Sweep
Publikováno v:
ResearcherID
Therapeutic Drug Monitoring, 36, pp. 765-770
Therapeutic drug monitoring, 36(6), 765-770. Lippincott Williams and Wilkins
Therapeutic Drug Monitoring, 36, 765-770
Therapeutic Drug Monitoring, 36, pp. 765-770
Therapeutic drug monitoring, 36(6), 765-770. Lippincott Williams and Wilkins
Therapeutic Drug Monitoring, 36, 765-770
Item does not contain fulltext BackgroundThe use of therapeutic monoclonal antibodies for clinical purposes has significantly increased in recent years, and so has the need to monitor antibody concentrations. This may be achieved using the well-estab
Publikováno v:
Radiotherapy and Oncology, 101, 198-202
Radiotherapy and Oncology, 101, 1, pp. 198-202
Radiotherapy and Oncology, 101, 1, pp. 198-202
Contains fulltext : 97392.pdf (Publisher’s version ) (Closed access) BACKGROUND: Tribbles homolog 3 (TRIB3) is a pseudokinase involved in the regulation of several signaling pathways involved in cell survival and/or cell stress. Here, we determined
Autor:
Viktor Magdolen, Valérie Gratio, Mekdes Debela, Dalila Darmoul, Josefine Maier, G. Duke Virca, Nathalie Beaufort, Nicolai Grebenchtchikov, Lina Seiz
Publikováno v:
The American Journal of Pathology. 176:1452-1461
Certain serine proteases are considered to be signaling molecules that act through protease-activated receptors (PARs). Our recent studies have implicated PAR1 and PAR4 (thrombin receptors) and PAR2 (trypsin receptor) in human colon cancer growth. He
Autor:
Dorine W. Swinkels, Anneke Geurts-Moespot, Annelies E. van Ede, Jack F.M. Wetzels, Peter Pickkers, Nicolai Grebenchtchikov, Hilde P.E. Peters, Fred C.G.J. Sweep, Joyce J.C. Kroot, Harold Tjalsma, Coby M. Laarakkers, Edmee C. Van Dongen-Lases
Publikováno v:
Clinical Chemistry, 56, 10, pp. 1570-9
Clinical Chemistry, 56, 1570-9
Clinical Chemistry, 56, 1570-9
BACKGROUND Hepcidin is an iron-regulatory peptide hormone that consists of 3 isoforms: bioactive hepcidin-25, and inactive hepcidin-22 and hepcidin-20. Hepcidin is instrumental in the diagnosis and monitoring of iron metabolism disorders, but reliabl
Autor:
Nicolai Grebenchtchikov, Jack A. Schalken, Lambertus A. Kiemeney, Fred C.G.J. Sweep, Paula M.J. Moonen, Paul N. Span, J.A. Witjes, Anneke Geurts-Moespot, Tilly Aalders, J.L.J. Vriesema
Publikováno v:
BJU International, 102, 177-82
BJU International, 102, 2, pp. 177-82
BJU International, 102, 2, pp. 177-82
Contains fulltext : 71373.pdf (Publisher’s version ) (Closed access) OBJECTIVE: To analyse and compare the concentration of plasminogen activator (PA), urokinase-type PA (uPA), tissue-type PA (tPA), PA inhibitor (PAI)-1 and PAI-2, and the complexes
Autor:
K. O’Brien, E. W. McDermott, Michael J. Duffy, Viktor Magdolen, Anneke Geurts-Moespot, D Evoy, Eadaoin McKiernan, John W.M. Martens, Fred C.G.J. Sweep, Anieta M. Sieuwerts, Nicolai Grebenchtchikov, J.P. Crown
Publikováno v:
British Journal of Cancer, 99, 1644-50
British Journal of Cancer
British Journal of Cancer, 99(10), 1644-1650. Nature Publishing Group
British Journal of Cancer, 99, 10, pp. 1644-50
British Journal of Cancer
British Journal of Cancer, 99(10), 1644-1650. Nature Publishing Group
British Journal of Cancer, 99, 10, pp. 1644-50
Contains fulltext : 71340.pdf (Publisher’s version ) (Closed access) The protein kinase C (PKC) family of genes encode serine/threonine kinases that regulate proliferation, apoptosis, cell survival and migration. Multiple isoforms of PKC have been